Puma Biotechnology, Inc.

PBYI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 14, 2024 PRIMARY DOCUMENT
SC 13G/A Feb 13, 2024 SCHEDULE 13G/A
SC 13G/A Feb 6, 2024 PUMA BIOTECHNOLOGY, INC.
SC 13G/A Jan 30, 2024
8-K Jan 18, 2024 FORM 8-K
4 Jan 10, 2024 FORM 4
144/A Jan 10, 2024
4 Jan 5, 2024 FORM 4
4 Jan 5, 2024 FORM 4
4 Jan 5, 2024 FORM 4
4 Jan 5, 2024 FORM 4
4 Jan 5, 2024 FORM 4
144 Jan 3, 2024
144 Jan 3, 2024
144 Jan 3, 2024
144 Jan 3, 2024
144 Jan 3, 2024
4 Nov 9, 2023 FORM 4
144 Nov 7, 2023
10-Q Nov 2, 2023 FORM 10-Q
8-K Nov 2, 2023 FORM 8-K
8-K Sep 26, 2023 FORM 8-K
SC 13G Sep 1, 2023 PUMA BIOTECHNOLOGY, INC.
8-K Aug 18, 2023 FORM 8-K
10-Q Aug 3, 2023 FORM 10-Q
← Newer Page 8 of 45 · 1122 filings Older →